Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.
第一作者:
M,Michael
第一单位:
1] Division of Cancer Medicine, Lower Gastrointestinal Tumour Service, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia [2] The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia.
作者:
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);队列研究(Cohort Studies);可行性研究(Feasibility Studies);女(雌)性(Female);氟尿嘧啶(Fluorouracil);随访研究(Follow-Up Studies);人类(Humans);醛氢叶酸(Leucovorin);肝肿瘤(Liver Neoplasms);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤分期(Neoplasm Staging);有机铂化合物(Organoplatinum Compounds);盆腔肿瘤(Pelvic Neoplasms);预后(Prognosis);放射治疗剂量(Radiotherapy Dosage);直肠肿瘤(Rectal Neoplasms);存活率(Survival Rate)
DOI
10.1038/bjc.2014.487
PMID
25211659
发布时间
2023-11-10
- 浏览28

British journal of cancer
1924-31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文